Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Role of vasopressin and vasopressin antagonists in heart failure reviewed at recent congress

July 20, 2000

Dual ETA/ETB receptor antagonists claimed by Kowa as cardiovascular therapeutics

July 19, 2000

BMS to conduct new study of omapatrilat as treatment for hypertension

July 18, 2000

Potent benzomaltoside-based inhibitors of smooth muscle cell proliferation

July 18, 2000

CVT-2759 as an alternative to adenosine A1 receptor full agonists

July 18, 2000

CETP inhibitor JTT-705 favorably affects lipid profiles, prevents progression of atherosclerosis

July 17, 2000

Two new cardiovascular genes selected in Transgene/HGS collaboration

July 14, 2000

New series under development at Glaxo Wellcome inhibits hepatic ApoB-100 production

July 12, 2000

Pharmacokinetics and pharmacodynamics of selective ETA antagonist examined in humans

July 12, 2000

Japanese laboratories discover naturally produced chymase inhibitors

July 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...